1. Ahmed, A., Wernock, M., Nieman, M., Srikanth, S., Mahdi, F., Krishnan, R., Tulinsky, A., and Schmaier, A., Mechanisms of Arg-Pro-Gly-Phe inhibition of thrombin, J. Physiol. Heard Circ. Physiol., 2003, vol. 285, pp. 183–193.
2. Ashmarin, I.P., Patologicheskaya fiziologiya i biokhimiya (Pathological Physiology and Biochemistry), Moscow: Ekzamen, 2005.
3. Ashmarin, I.P., Lyapina, L.A., Andreeva, L.A., Ul’yanov, A.M., Pastorova, V.E., Obergan, T.Yu., Alferova, L.Yu., and Myasoedov, N.F., Effect of glyprolines Pro-Gly and Pro-GlyPro at development of experimental insulin-dependent diabetes, Tromboz, Gemostaz, Reologiya, 2008, vol. 34, no. 2, pp. 38–43.
4. Andreeva, L.A., Myasoedov, N.F., Lyapina, L.A., Grigor’eva, M.E., Obergan, T.Y., and Shubina, T.A., Effect of the PRO-GLY-PRO peptide on hemostasis and lipid metabolism in rats with hypercholesterolemia, Dokl. Biol. Sci., 2013, vol. 453, no. 1, pp. 333–335.
5. Balabolkin, M.I., Klebanova, E.M., and Ereminskaya, V.M., Differential diagnostics and treatment of endocrine diseases, in Rukovodstvo dlya endokrinologov, vrachei shirokogo profilya (Manual for Endocrinologists and General Physicians), Moscow: MIA, 2008.